Search for Clinical Trial Results

Sponsored By

Lymphangioleiomyomatosis - 18 Studies Found

Status Study
Recruiting Study Name: National Lymphangioleiomyomatosis Registry, France
Condition: Lymphangioleiomyomatosis
Date: 2011-11-30
Recruiting Study Name: Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
Condition: Lymphangioleiomyomatosis
Date: 2006-12-20
Interventions:
  • Drug: Sirolimus A sirolimus do
Completed Study Name: Pulmonary Rehabilitation in Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Date: 2013-12-04
Interventions: Other: Pulmonary Rehabilitation
Completed Study Name: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Condition: Pulmonary Lymphangioleiomyomatosis
Date: 2014-04-15
Interventions: Drug: Saracatinib Saracatinib is escalated as follows: Three dose levels will be administered for 1 mont
Completed Study Name: Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Date: 2011-05-11
Interventions:
  • Drug: Letrozole 2.5 mg daily f
Completed Study Name: A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Date: 2010-01-28
Interventions: Drug: Everolimus
Recruiting Study Name: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
Condition: Lymphangioleiomyomatosis
Date: 2016-10-07
Interventions: Drug: Nintedanib Other Name: OFEV
Recruiting Study Name: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Date: 2013-02-23
Interventions:
  • Drug: albuterol inhaler
  • Procedure: PFT
Recruiting Study Name: Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Condition: Pulmonary Lymphangioleiomyomatosis
Date: 2016-03-31
Interventions: Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi
Completed Study Name: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Date: 2012-08-02
Interventions: Drug: sirolimus and hydroxychloroquine This will be a phase I dose escalation study of the combination o
Next >>>